RMBS GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Rambus Inc
Exchange: NASDAQSector: TechnologyIndustry: Semiconductors
Rambus is a provider of industry-leading chips and silicon IP making data faster and safer. With 35 years of advanced semiconductor experience, we are a pioneer in high-performance memory solutions that solve the bottleneck between memory and processing for data-intensive systems. Whether in the cloud, at the edge or in your hand, real-time and immersive applications depend on data throughput and integrity. Rambus products and innovations deliver the increased bandwidth, capacity and security required to meet the world’s data needs and drive ever-greater end-user experiences.
Did you know?
Capital expenditures decreased by 13% from FY24 to FY25.
Current Price
$111.50
-0.38%GoodMoat Value
$73.37
34.2% overvaluedProfile
Valuation (TTM)
Market Cap$12.02B
P/E52.25
EV—
P/B8.81
Shares Out107.79M
P/Sales16.67
Revenue$721.15M
EV/EBITDA34.40
Rambus Inc (RMBS) Quality Analysis
RMBS Profitability
Profitability trend analysis coming soon
RMBS Growth
Growth trend analysis coming soon
RMBS Financial Health
Financial health indicators coming soon
RMBS Quality & Fundamental Analysis
Rambus Inc (RMBS) is a Technology company in the Semiconductors industry, listed on NASDAQ. This quality analysis page evaluates Rambus Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Rambus Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 31.89% and a return on equity (ROE) of 16.86%. Return on assets (ROA) stands at 15.04%.
The debt-to-equity ratio is 0.03, with a current ratio of 8.20. Operating margin is 36.77%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Rambus Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.